At Adimab, we leverage our proprietary yeast-based antibody discovery and optimization platform to provide the biopharmaceutical industry with human therapeutic antibodies of the highest quality. We partner with top-tier pharmaceutical companies, progressive academic institutions, and innovative biotechnology companies who share our passion for bringing best-in-class molecules to patients.
Adimab has established antibody discovery collaborations with many leading pharmaceutical companies, such as Merck, Novo Nordisk, Biogen, GSK, Roche, Novartis, Eli Lilly, Genentech, Celgene, Gilead, Kyowa Hakko Kirin, Takeda, and Sanofi. The Adimab antibody discovery and optimization platform has been internalized by several pharma partners; Adi-inside partners include Merck, Novo Nordisk, Biogen, and GSK. In addition, Adimab has partnered with several smaller publicly traded companies, such as Acceleron, Merrimack Pharmaceuticals, Kite, and Five Prime, as well as leading venture-backed companies including Jounce, Mersana, Alector, Arsanis, Surface Oncology, Potenza, Tizona, Tusk, and several academic institutions such as Memorial Sloan Kettering and MD Anderson.
The Predoctoral Program
Adimab’s Predoctoral Program is a 24-month program that will offer you a unique opportunity to receive meaningful research experience in an innovative entrepreneurial environment. The program is designed for individuals looking to gain two years of industry experience before moving on to a top-tier graduate program.
As an Adimab predoc, you will work on cutting-edge science and have the opportunity to make an immediate impact. Consistent with our belief that great ideas can come from anyone, we expect predocs to actively contribute to the research process. Using Adimab’s state-of-the-art yeast-based antibody discovery platform, you will work with a team of experienced scientists on key projects that will help drive the company forward.
In addition to rigorous scientific training, you will receive career mentorship and assistance with the graduate school application process. At Adimab, we are committed to developing our people. Our goal is 100% placement of all predocs in a top-tier Ph.D. program.
Adimab is a leader in antibody discovery, and we are growing rapidly. We offer competitive salaries, great benefits, and a high-energy culture with lots of opportunity for personal and professional growth.
Successful candidates will work in a small team setting to support Adimab's novel antibody discovery, maturation, and production platform through:
Needed upon hire
Our integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. We offer fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity, and developability. We enable our partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.
As a profitable privately-held biotech company, we take a long-term view on value creation and make substantial investments in technology development, research, and our people. We proudly promote meritocracy and reward employees who are productive, use their resources wisely, and make meaningful contributions to the team. We offer individually tailored compensation packages comprised of competitive salary, equity, a 2:1 401(k) match, and comprehensive health care benefits.
Located in New Hampshire’s beautiful Upper Connecticut River Valley, Adimab is minutes from Dartmouth College, the Geisel School of Medicine, the Thayer School of Engineering, the Tuck School of Business, and the Dartmouth Hitchcock Medical Center. We are fortunate to be situated in an area that is renowned for its premier skiing, hiking, kayaking, and biking.